CLINICAL RELEVANCE OF CHEK2 AND NBN
MUTATIONS IN THE MACEDONIAN POPULATION
Maleva Kostovska I, Jakimovska M, Kubelka-Sabit K, Karadjozov M,
Arsovski A, Stojanovska L, Plaseska-Karanfilska D1,
*Corresponding Author: Dijana Plaseska-Karanfilska, M.D., Ph.D., Research Centre for Genetic Engineering
and Biotechnology “Geogi D. Efremov,” Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
Tel: +389-2-3235-410. Fax: +389-2-3155-434. E-mail: dijana@manu.edu.mk
page: 47
|
|
REFERENCES
1. Stratton MR, Rahman N. The emerging landscape
of breast cancer susceptibility. Nat Genet.
2008; 40(1): 17-22.
2. Nevanlinna H, Bartek J. The CHEK2 gene and
inherited breast cancer susceptibility. Oncogene.
2006; 25(43): 5912-5919.
3. Bell DW, Varley JM, Szydlo TE, Kang DH,
Wahrer DC, Shannon KE, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
Science. 1999; 286(5449): 2528-2531.
4. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K,
Ojala S, Kilpivaara O, et al. A CHEK2 genetic
variant contributing to a substantial fraction of
familial breast cancer. Am J Hum Genet. 2002;
71(2): 432-438.
5. Broeks A, de Witte L, Nooijen A, Huseinovic A,
Klijn JG, van Leeuwen FE, et al. Excess risk for
contralateral breast cancer in CHEK2*1100delC
germline mutation carriers. Breast Cancer Res
Treat. 2004; 83(1): 91-93.
6. Cybulski C, Huzarski T, Gorski B, Masojc B, Mier-
zejewski M, Debniak T, et al. A novel founder
CHEK2 mutation is associated with increased
prostate cancer risk. Cancer Res. 2004; 64(8):
2677-2679.
7. Bogdanova N, Enssen-Dubrowinskaja N, Feshchenko
S, Lazjuk GI, Rogov YI, Dammann
O, et al. Association of two mutations in the
CHEK2 gene with breast cancer. Int J Cancer.
2005; 116(2): 263-266.
8. Dufault MR, Betz B, Wappenschmidt B, Hofmann
W, Bandick K, Golla A, et al. Limited relevance
of the CHEK2 gene in hereditary breast
cancer. Int J Cancer. 2004; 110(3): 320-325.
9. Walsh T, Casadei S, Coats KH, Swisher E, Stray
SM, Higgins J, et al. Spectrum of mutations in
BRCA1, BRCA2, CHEK2, and TP53 in families
at high risk of breast cancer. JAMA. 2006;
295(12): 1379-1388.
10. Cybulski C, Wokołorczyk D, Huzarski T, Byrski
T, Gronwald J, Górski B, et al. A deletion in
CHEK2 of 5,395 bp predisposes to breast cancer
in Poland. Breast Cancer Res Treat. 2007;
102(1): 119-122.
11. Liu C, Wang Y, Wang QS, Wang YJ. The CHEK2
I157T variant and breast cancer susceptibility: A
systematic review and meta-analysis. Asian Pac
J Cancer Prev. 2012; 13(4): 1355-1360.
12. Varon R, Vissinga C, Platzer M, Cerosaletti
KM, Chrzanowska KH, Saar K, et al. Nibrin, a
novel DNA double-strand break repair protein, is
mutated in Nijmegen breakage syndrome. Cell.
1998; 93(3): 467-476.
13. Varon R, Seemanova E, Chrzanowska K, Hnateyko
O, Piekutowska-Abramczuk D, Krajewska-
Walasek M, et al. Clinical ascertainment
of Nijmegen breakage syndrome (NBS) and
prevalence of the major mutation, 657del5, in
three Slav populations. Eur J Hum Genet. 2000;
8(11): 900-902.
14. Bogdanova N, Feshchenko S, Schurmann P,
Waltes R, Wieland B, Hillemanns P, et al. Nijmegen
breakage syndrome mutations and risk of
breast cancer. Int J Cancer. 2008; 122(4): 802-806.
15. Maleva I, Madjunkova S, Bozhinovski G,
Smickova E, Kondov G, Spiroski Z, et al. Genetic
variation of the brca1 and brca2 genes
in Macedonian patients. Balkan J Med Genet.
2012; 15(Suppl): 81-85.
16. de Jong MM, van der Graaf WTA, Nolte IM, Te
Meerman GJ, Oosterwijk JC, van der Steege G,
et al. Increased CHEK2 1100delC genotype frequency
(also) in unselected breast cancer patients
(conference abstract). American Society of Clinical
Oncology Annual Meeting Proceedings (Post-
Meeting Edition), New Orleans, LA, USA, June
5-8 2004. J Clin Oncol. 2004; 22(14S): 9536.
17. Einarsdottir K, Humphreys K, Bonnard C,
Palmgren J, Iles MM, Sjolander A, et al. Linkage
disequilibrium mapping of CHEK2: Common
variation and breast cancer risk. PLoS
Med. 2006; 3(6): e168. doi: 10.1371/ journal.
pmed.0030168.
18. Weischer M, Bojesen SE, Tybjaerg-Hansen A,
Axelsson CK, Nordestgaard BG. Increased risk of
breast cancer associated with CHEK2*1100delC.
J Clin Oncol. 2007; 25(1): 57-63.
19. Mateus Pereira LH, Sigurdson AJ, Doody MM,
Pineda MA, Alexander BH, Greene MH, et al.
CHEK2: 1100delC and female breast cancer in
the United States. Int J Cancer. 2004; 112(3):
541-543.
20. Rashid MU, Jakubowska A, Justenhoven C, Harth
V, Pesch B, Baisch C, et al. German populations
with infrequent CHEK2*1100delC and minor
associations with early-onset and familial breast
cancer. Eur J Cancer. 2005; 41(18): 2896-2903.
21. Kleibl Z, Novotny J, Bezdickova D, Malik R,
Klei-blova P, Foretova L, et al. The CHEK2
c.1100delC germline mutation rarely contributes
to breast cancer development in the Czech
Republic. Breast Cancer Res Treat. 2005; 90(2):
165-167.
22. Krivokuca A, Dobricic J, Brankovic-Magic M.
CHEK2 1100delC and Del5395bp mutations in
BRCA-negative individuals from Serbian hereditary
breast and ovarian cancer families. J
BUON. 2013; 18(3): 594-600.
23. Bogdanova N, Feshchenko S, Cybulski C, Dork
T. CHEK2 mutation and hereditary breast cancer.
J Clin Oncol. 2007; 25(19): e26. doi: 10.1200/
JCO.2007.11.4223.
24. Domagala P, Wokolorczyk D, Cybulski C, Huzarski
T, Lubinski J, Domagala W. Different
CHEK2 germline mutations are associated with
distinct immunophenotypic molecular subtypes
of breast cancer. Breast Cancer Res Treat. 2012;
132(3): 937-945.
25. Cybulski C, Gorski B, Huzarski T, Byrski T,
Gronwald J, Debniak T, et al. Effect of CHEK2
missense variant I157T on the risk of breast
cancer in carriers of other CHEK2 or BRCA1
mutations. J Med Genet. 2009; 46(2):.132-135.
26. Serrano-Fernandez P, Debniak T, Gorski B, Bogdanova
N, Dork T, Cybulski C, et al. Synergistic
interaction of variants in CHEK2 and BRCA2
on breast cancer risk. Breast Cancer Res Treat.
2009; 117(1): 161-165.
27. Kleibl Z, Havranek O, Hlavata I, Novotny J,
Sevcik J, Pohlreich P, et al. The CHEK2 gene
I157T mutation and other alterations in its proximity
increase the risk of sporadic colorectal
cancer in the Czech population. Eur J Cancer.
2009; 45(4): 618-624.
28. Gorski B, Cybulski C, Huzarski T, Byrski T,
Gronwald J, Jakubowska A, et al. Breast cancer
predisposing alleles in Poland. Breast Cancer
Res Treat. 2005; 92(1): 19-24.
29. Steffen J, Nowakowska D, Niwinska A, Czapczak
D, Kluska A, Piatkowska M, et al. Germline
mutations 657del5 of the NBS1 gene contribute
significantly to the incidence of breast cancer
in Central Poland. Int J Cancer. 2006; 119(2):
472-475.
30. Carlomagno F, Chang-Claude J, Dunning AM,
Ponder BA. Determination of the frequency of
the common 657Del5 Nijmegen breakage syndrome
mutation in the German population: No
association with risk of breast cancer. Genes
Chromosomes Cancer. 1999; 25(4): 393-395.
31. Mateju M, Kleiblova P, Kleibl Z, Janatova M,
Soukupova J, Ticha I, et al. Germline mutations
657del5 and 643C>T (R215W) in NBN are not
likely to be associated with increased risk of
breast cancer in Czech women. Breast Cancer
Res Treat. 2012; 133(2): 809-811.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
